Canara HSBC Life Insurance Company Limited has entered into a strategic Corporate Agency Agreement with Bihar Gramin Bank on 11th March 2026, expanding its distribution network for insurance products. The partnership represents a significant step in the company's efforts to enhance market reach through banking channel partnerships.

Partnership Details

The agreement establishes Bihar Gramin Bank as a corporate agent for distributing Canara HSBC Life's insurance products. Bihar Gramin Bank is a banking company constituted under Section 3 of Regional Rural Bank Act, 1976, and operates as an associate of Punjab National Bank.

Commercial Arrangements

Under the terms of the agreement, Canara HSBC Life will compensate Bihar Gramin Bank through a commission structure aligned with the company's Board-approved commission policy. The partnership does not involve any shareholding arrangements between the parties, with both entities maintaining their independent operational structures.

Regulatory Compliance

The company has confirmed that this transaction does not fall within the scope of related party transactions, despite Bihar Gramin Bank's association with Punjab National Bank. The agreement has been structured to ensure compliance with regulatory requirements and maintains arm's length commercial terms.

Strategic Implications

This partnership aligns with Canara HSBC Life's distribution strategy of leveraging banking networks to reach customers across different market segments. The collaboration with Bihar Gramin Bank, which serves rural and semi-urban markets, potentially enhances the company's presence in these underserved segments. The agreement follows standard corporate agency frameworks without creating any special rights or complex structural arrangements between the parties.

Canara HSBC Life Insurance Company Limited has successfully concluded its Debt Raising Committee meeting on March 6, 2026, approving the Key Information Document for its subordinated debt instrument issuance worth ₹250 crores. The committee meeting, which commenced at 9:45 am and concluded at 10:00 am, marked a significant milestone in the company's fundraising initiative through Non-convertible Debentures (NCDs).

Board Approval and Committee Formation

The foundation for this debt raising exercise was established through a systematic approval process. The Board of Directors initially approved the subordinated debt instrument issuance on January 21, 2026, authorizing the raising of funds through Non-convertible Debentures (NCDs). Subsequently, the Board constituted a specialized Debt Raising Committee on February 9, 2026, to handle the technical documentation and approval processes.

Committee Meeting Outcome

The Debt Raising Committee approved the Key Information Document containing commercial terms for the proposed debt issuance. The meeting represents the completion of a crucial step in finalizing the structure and terms of the subordinated debt instruments before proceeding with the private placement process. The company formally notified both NSE and BSE about the meeting outcome under Regulation 30 compliance requirements.

Debt Instrument Characteristics

The approved NCDs are structured with specific features to meet regulatory requirements for insurance companies and qualify as subordinated debt:

Terms and Conditions

The Debt Raising Committee has delegated authority to Authorised Persons to finalize specific commercial terms including the date of allotment, maturity date, and coupon/interest rates. These details will be disclosed in the relevant Key Information Document. In case of payment defaults exceeding three months, the company will pay interest at a rate 2% per annum above the standard interest rate until the default is resolved to the satisfaction of the Debenture Trustee.

The subordinated nature of these debentures means they rank lower in priority compared to other debts in liquidation scenarios, while the private placement approach provides flexibility in terms and timing by targeting qualified institutional investors rather than public subscription.